Autres langues AFT Pharmaceuticals Limited

Actions

AFT

NZAFTE0001S4

Produits pharmaceutiques

Cours en clôture New Zealand S.E. 18/08/2026			Varia. 5j.	Varia. 1 janv.
4,250 ^NZD	-1,16%		-7,61%	+25,74%

31/07	Transcript : AFT Pharmaceuticals Limited - Shareholder/Analyst Call
31/07	La Bourse de Nouvelle-Zélande clôture en baisse ; le président d'AFT Pharmaceuticals annonce son départ	MT

Autres langues

31/07	New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire
31/07	AFT Pharmaceuticals Limited Reiterates Earnings Guidance for Fiscal Year 2027
28/07	AFT Pharmaceuticals Says R&D Portfolio Targeting Multi-Billion-Dollar Market Potential
24/07	AFT Pharmaceuticals Offers an Attractive Risk-Reward Profile With an Expanding Clinical Pipeline, Pitt Street Research Says
21/07	New Zealand Shares Fall; Contact Energy Posts Higher Retail Electricity, Gas Sales in June
21/07	Aft Pharmaceuticals Announces Tentative Approval for Scomara Rapamycin 0.5% Cream by US Fda
21/07	AFT Pharmaceuticals' Topical Cream Secures Tentative US FDA Approval
15/07	Hyloris Pharmaceuticals' Partner Strikes Exclusive Licensing Deal for Painkiller Maxigesic in China
07/07	AFT Pharmaceuticals On Track to Achieve Fiscal 2027 Revenue Target; Iron Injectable Product Clears Regulatory Hurdles
24/06	NZX Biggest Gainers
24/06	AFT Pharmaceuticals Gets US FDA Nod for Phase 3 Trial of Injectable Iron Therapy
12/06	NZX Biggest Losers
21/05	AFT Pharmaceuticals : FY26 Results Presentation
21/05	AFT Pharmaceuticals Posts Higher Fiscal 2026 Earnings, Revenue; Shares Reach Three-Year High
21/05	AFT Pharmaceuticals Posts Higher Fiscal 2026 Earnings, Revenue
21/05	AFT Pharmaceuticals Limited announces Annual dividend, payable on July 03, 2026
20/05	AFT Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027
20/05	AFT Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026
20/05	AFT Pharmaceuticals targets FY27 revenue above NZ$300 mln
18/05	New Zealand Shares Fall; AFT Pharmaceuticals Appoints CFO
18/05	AFT Pharmaceuticals names Stuart Houliston CFO
18/05	AFT Pharmaceuticals Appoints CFO
17/05	AFT Pharmaceuticals Limited Appoints Stuart Houliston as Chief Financial Officer, Effective June 15, 2026
07/04	AFT Pharmaceuticals provides March quarter investor update
07/04	AFT Pharmaceuticals Expects Record Fiscal 2026 Sales; Strikes US Distribution Deal for Pain Relief Tablets; Shares Up 4%